Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production

Infection and Immunity

Volumn 71, Issue 4, 2003, Pages 1887-1896

  Bermúdez Humarán, Luis G ^a,b   Langella, Philippe ^a   Cortes Perez, Naima G ^b   Gruss, Alexandra ^a   Tamez Guerra, Reyes S ^b   Oliveira, Sergio C ^d   Saucedo Cardenas, Odila ^c   Montes de Oca Luna, Roberto ^b   Le Loir, Yves ^a  

^a CEMAGREF   (France)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; GAMMA INTERFERON; HUMAN PAPILLOMAVIRUS TYPE 16 E7 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2; POLYPEPTIDE; POLYPEPTIDE P35; POLYPEPTIDE P40; POLYPEPTIDE SCIL 12; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; IMMUNE RESPONSE; IMMUNIZATION; INTERFERON PRODUCTION; LACTOCOCCUS LACTIS; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN FOLDING; RECOMBINANT BACTERIUM; SEQUENCE ANALYSIS; SPLEEN CELL; TH1 CELL; VACCINE PRODUCTION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-2; LACTOCOCCUS LACTIS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; RECOMBINATION, GENETIC; SPLEEN; TH1 CELLS;

EID: 3042659382     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.4.1887-1896.2003     Document Type: Article

References (61)

1. Afonso, L. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263:235-237.
2. al-Saleh, W., S. L. Giannini, N. Jacobs, M. Moutschen, J. Doyen, J. Boniver, and P. Delvenne. 1998. Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J. Pathol. 184:283-290.
3. Arulanandam, B. P., M. O'Toole, and D. W. Metzger. 1999. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J. Infect. Dis. 180:940-994.
4. Barth, H., R. Klein, P. A. Berg, B. Wiedenmann, U. Hopf, and T. Berg. 2001. Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B. Hepatogastroenterology 48:553-555.
5. Bermúdez-Humarán, L. G., P. Langella, A. Miyoshi, A. Gruss, R. S. Tamez-Reyes, R. Montes de Oca-Luna, and Y. Le Loir. 2002. Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl. Environ. Microbiol. 68:917-922.
6. Boyaka, P. N., and J. R. McGhee. 2001. Cytokines as adjuvants for the induction of mucosal immunity. Adv. Drug Deliv. Rev. 51:71-79.
7. Brunda, M., L. Luistro, R. Warrier, R. Wright, B. Hubbard, M. Murphy, S. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178:1223-1230.
8. Chan, S. H., B. Perussia, J. W. Grupta, M. Kobayashi, M. Pospisil, H. A. Young, S. G. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
9. Chen, B., T. M. Timiryasova, D. S. Gridley, M. L. Andres, R. Dutta-Roy, and I. Fodor. 2001. Evaluation of cytokine toxicity induced by vaccinia virusmediated IL-2 and IL-12 antitumour immunotherapy. Cytokine 15:305-334.
10. Cohen, J. 1995. IL-12 deaths: explanation and a puzzle. Science 270:908.
11. de Ruyter, P. G., O. P. Kuipers, and W. M. de Vos. 1996. Controlled gene expression systems for Lactococcus lactis with the food-grade inducer nisin. Appl. Environ. Microbiol. 62:3662-3667.
12. Drouault, S., G. Corthier, S. D. Ehrlich, and P. Renault. 1999. Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl. Environ. Microbiol. 65:4881-4886.
13. Enouf, V., P. Langella, J. Commissaire, J. Cohen, and G. Corthier. 2001. Bovine rotavirus nonstructural protein 4 produced by Lactococcus lactis is antigenic and immunogenic. Appl. Environ. Microbiol. 67:1423-1428.
14. Gasson, M. J. 1983. Plasmid complements of Streptococcus lactis NCDO 712 and other lactic acid streptococci after protoplast-induced curing. J. Bacteriol. 154:1-9.
15. Gaucher, D., and K. Chadee. 2001. Molecular cloning of gerbil interleukin 12 and its expression as a bioactive single-chain protein. Cytokine 14:177-183.
16. Geoffroy, M. C., C. Guyard, B. Quatannens, S. Pavan, M. Lange, and A. Mercenier. 2000. Use of green fluorescent protein to tag lactic acid bacterium strains under development as live vaccine vectors. Appl. Environ. Microbiol. 66:383-391.
17. Gherardi, M. M., J. C. Ramirez, and M. Esteban. 2000. Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 Env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide. J. Virol. 74:6278-6286.
18. Ghim, S. J., J. Sundberg, G. Delgado, and A. B. Jenson. 2001. The pathogenesis of advanced cervical cancer provides the basis for an empirical therapeutic vaccine. Exp. Mol. Pathol. 71:181-185.
19. Gibson, T. J. 1984. Ph.D. thesis. University of Cambridge, Cambridge, England.
20. Gillessen, S., D. Carvajal, P. Ling, F. J. Podlaski, D. L. Stremlo, P. C. Familletti, U. Gubler, D. H. Presky, A. S. Stern, and M. K. Gately. 1995. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur. J. Immunol. 25:200-206.
21. Graham, B. S., G. S. Henderson, Y. W. Tang, X. Lu, K. M. Neuzil, and D. G. Colley. 1993. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J. Immunol. 151:2032-2040.
22. Grangette, C., H. Muller-Alouf, M. Geoffroy, D. Goudercourt, M. Turneer, and A. Mercenier. 2002. Protection against tetanus toxin after intragastic administration of two recombinant lactic acid bacteria: impact of strain variability and in vivo persistence. Vaccine 20:3304-3309.
23. Gubler, U., A. O. Chua, D. S. Schoenhaut, C. M. Dwyer, W. McComas, R. Motyka, N. Mabavi, A. G. Wolitzky, P. M. Quinn, P. C. Familletti, and M. K. Gately. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88:4143-4147.
24. Hoover, D. L., R. M. Crawford, L. L. Van De Verg, M. J. Izadjoo, A. K. Bhattacharjee, C. M. Paranavitana, R. L. Warren, M. P. Nikolich, and T. L. Hadfield. 1999. Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK). Infect. Immun. 67:5877-5884.
25. Hultgren, O. H., M. Stenson, and A. Tarkowski. 2001. Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis. Arthritis Res. 3:41-47.
26. Jacobson, M. A., D. Hardy, E. Connick, J. Watson, and M. DeBruin. 2000. Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microl. J. Infect. Dis. 182:1070-1076.
27. Jiang, C., D. M. Magee, and R. A. Cox. 1999. Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis. Infect. Immun. 67:2996-3001.
28. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chang, R. Koudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827-845.
29. Kokuho, T., S. Watanabe, Y. Yokomizo, and S. Inumaru. 1999. Production of biologically active, heterodimeric porcine interleukin-12 using a monocistronic baculoviral expression system. Vet. Immunol. Immunopathol. 72:289-302.
30. Kuipers, O. P., P. G. de Ruyter, M. Kleerebezen, and W. M. de Vos. 1998. Quorum sensing-controlled gene expression in lactic acid bacteria. J. Biotechnol. 64:15-21.
31. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
32. Langella, P., Y. Le Loir, S. D. Ehrlich, and A. Gruss. 1993. Efficient plasmid mobilization by pIP501 in Lactococcus lactis subsp. lactis. J. Bacteriol. 175:5806-5813.
33. Lee, M. H., Y. Roussel, M. Wilks, and S. Tabaqchali. 2001. Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice. Vaccine 19:3927-3935.
34. Lee, S., M. Zheng, S. Deshpande, S. K. Eo, T. A. Hamilton, and B. T. Rouse. 2002. IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis. J. Leukoc. Biol. 71:469-476.
35. Le Loir, Y., A. Gruss, S. D. Ehrlich, and P. Langella. 1998. A nine-residue synthetic propeptide enhances secretion efficiency of heterologous proteins in Lactococcus lactis. J. Bacteriol. 180:1895-1903.
36. Leonard, J. P., M. L. Sherman, G. L. Fisher, L. J. Buchanan, G. Larsen, M. B. Atkins, J. A. Sosman, J. P. Dutcher, N. J. Vogelzang, and J. L. Ryan. 1997. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90:2541-2548.
37. Ling, P., M. K. Gately, U. Gubler, A. S. Stern, P. Lin, K. Hollfelder, C. Su, Y.-C. E. Pan, and J. Hakimi. 1995. Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity. J. Immunol. 154:116-127.
38. Lui, V. W., L. D. Falo, and L. Huang. 2001. Systemic production of IL-12 by naked DNA mediated gene transfer: toxicity and attenuation of transgene expression in vivo. J. Gene Med. 3:384-393.
39. Magee, D. M., and R. A. Cox. 1996. Interleukin-12 regulation of host defenses against Coccidioides immitis. Infect. Immun. 64:3609-3613.
40. Mazzolini, G., I. Narvaiza, A. Perez-Diez, M. Rodriguez-Calvillo, C. Qian, B. Sangro, J. Ruiz, J. Prieto, and I. Melero. 2001. Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12. Gene Ther. 8:259-267.
41. Metzger, D. W., R. M. McNutt, J. T. Collins, J. M. Buchanan, V. H. Van Cleave, and W. A. Dunnick. 1997. Interleukin-12 acts as an adjuvant for humoral immunity through interferon-gamma-dependent and -independent mechanisms. Eur. J. Immunol. 27:1958-1965.
42. Michel, N., W. Osen, L. Gissmann, T. N. Schumacher, H. Zentgraf, and M. Muller. 2002. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. Virology 294:47-59.
43. Nastala, C., H. Edington, T. McKinney, H. Tahara, M. Nalesnik, M. Brunda, M. K. Gately, S. Wolf, R. Schreiber, W. Storkus, and M. Lotze. 1994. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. J. Immunol. 153:1697-1703.
44. Paik, S. H., A. Chakicherla, and J. N. Hansen. 1998. Identification and characterization of the structural and transporter genes for, and the chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168. J. Biol. Chem. 273:23134-23142.
45. Park, A. Y., B. Hondowicz Hondowiez, M. Kopf, and P. Scott. 2002. The role of IL-12 in maintaining resistance to Leishmania major. J. Immunol. 168:5771-5777.
46. Payne, M. S., and E. N. Jackson. 1991. Use of alkaline phosphatase fusions to study protein secretion in Bacillus subtilis. J. Bacteriol. 173:2278-2282.
47. Podlaski, F. J., V. B. Nanduri, J. D. Hulmes, Y. C. Pan, W. Levin, W. Danho, R. Chizzonite, M. K. Gately, and A. S. Stern. 1992. Molecular characterization of interleukin 12. Arch. Biochem. Biophys. 294:230-237.
48. Poquet, I., S. D. Ehrlich, and A. Gruss. 1998. An export-specific reporter designed for gram-positive bacteria: application to Lactococcus lactis. J. Bacteriol. 180:1904-1912.
49. Rakhmilevich, A. L., J. Turner, M. J. Ford, D. McCabe, W. H. Sun, P. M. Sondel, K. Grota, and N.-Y. Yang. 1996. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established and metastatic murine tumors. Proc. Natl. Acad. Sci. USA 93:6291-6296.
50. Robinson, K., L. M. Chamberlain K. M. Schofield, J. M. Wells, and R. W. 1997. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis. Nat. Biotechnol. 15:653-657.
51. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
52. Shen, H., C. Li, M. Lin, Z. Zhang, and Q. Shen. 1998. Expression of human interleukin 12 (hIL-12) in insect cells. Chin. J. Biotechnol. 14:205-212.
53. + T cell-mediated protective immunity against herpes simplex virus-2 challenge. J. Immunol. 162:2912-2921.
54. Sinkovics, J. G., and J. C. Horvath. 2000. Vaccination against human cancers. Int. J. Oncol. 16:81-96.
55. Steidler, L., K. Robinson, L. Chamberlain, K. M. Schofield, E. Remaut, R. W. Le Page, and J. M. Wells. 1998. Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine. Infect. Immun. 66:3183-3189.
56. Steidler, L., W. Hans, L. Schotte, S. Neirynck, F. Obermeier, W. Falk, W. Fiers, and E. Remaut. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352-1355.
57. Takehara, K., T. Nagata, R. Kikura, T. Takanashi, S. Yoshiya, and A. Yamaga. 2000. Expression of a bioactive interleukin-12 using baculovirus. Vet. Immunol. Immunopathol. 77:15-25.
58. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
59. van Asseldonk, M., G. Rutten, M. Oteman, R. J. Siezen, W. M. de Vos, and G. Simons. 1990. Cloning, expression in Escherichia coli and characterization of usp45, a gene encoding a highly secreted protein from Lactococcus lactis MG1363. Gene 95:155-160.
60. Voest, E. E., B. M. Kenyon, M. S. O'Reilly, G. Truitt, R. J. D'Amato, and J. Folkman. 1995. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst. 19:581-586.
61. Wilkinson, V. L., R. R. Warrier, T. P. Truitt, P. Nunes, M. K. Gately, and D. H. Presky. 1996. Characterization of anti-mouse IL-12 monoclonal anti-bodies and measurement of mouse IL-12 by ELISA. J. Immunol. Methods 189:15-24.